Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary

Nonalcoholic fatty liver disease (NAFLD) develops when the liver is unable to oxidize or export excess free fatty acids generated by adipose tissue lipolysis, de novo lipogenesis, or dietary intake. Although treatment has generally been centered on reversing metabolic risk factors that increase the...

Full description

Bibliographic Details
Main Authors:	Pratima Dibba, Andrew A Li, George Cholankeril, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-05-01
Series:	Nutrition and Metabolic Insights
Online Access:	https://doi.org/10.1177/1178638819847480

Similar Items

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
by: Pratima Dibba, et al.
Published: (2018-05-01)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
by: Karn Wijarnpreecha, et al.
Published: (2021-04-01)

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
by: Donghee Kim, et al.
Published: (2017-01-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
by: Goh Eun Chung, et al.
Published: (2016-03-01)

The Role of Cannabinoids in the Setting of Cirrhosis
by: Pratima Dibba, et al.
Published: (2018-06-01)

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
by: Seung Joo Kang, et al.
Published: (2018-01-01)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
by: Brandon J. Perumpail, et al.
Published: (2017-10-01)

Potential therapeies for nonalcoholic fatty liver disease
by: XIE Xiao
Published: (2017-12-01)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Byoung Kuk Jang
Published: (2012-12-01)

Recent advances in liver transplantation with HCV seropositive donors [version 1; peer review: 2 approved]
by: Soumya Murag, et al.
Published: (2019-12-01)

Nonalcoholic Fatty Liver Disease
by: Bayard, Max, et al.
Published: (2006)

Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01)

Nonalcoholic fatty liver disease
by: Sandra K. Erickson
Published: (2009-01-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
by: Xiaopeng Zhu, et al.
Published: (2016-10-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Chanbin Lee, et al.
Published: (2019-10-01)

Liver regeneration in nonalcoholic fatty liver disease
by: Aldo Lagomarsino
Published: (2012-12-01)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
by: Goh Eun Chung, et al.
Published: (2015-01-01)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Koichiro Wada, et al.
Published: (2013-11-01)

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease
by: George Cholankeril, et al.
Published: (2017-09-01)

History of Nonalcoholic Fatty Liver Disease
by: Amedeo Lonardo, et al.
Published: (2020-08-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Nonalcoholic Fatty Liver Disease Treatment
by: M Sadeghian, et al.
Published: (2014-04-01)

Biomarkers in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2014-01-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

Nonalcoholic fatty liver disease associated with obesity: the potential of essential phospholipids
by: D. I. Trukhan
Published: (2016-12-01)

The potential of bitter melon in prevention of nonalcoholic fatty liver disease (NAFLD)
by: Zhong-Hao Chien, et al.
Published: (2011)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
by: Laia Bertran, et al.
Published: (2021-05-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Nonalcoholic fatty liver disease stratification by liver lipidomics
by: Olga Vvedenskaya, et al.
Published: (2021-01-01)

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
by: Pratima Dibba, et al.
Published: (2018-09-01)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
by: Wang Xin, et al.
Published: (2011-12-01)

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
by: Pipop Jirapinyo
Published: (2008-01-01)